✦ LIBER ✦

Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats

✍ Scribed by Saadia Eddahibi; Bernadette Raffestin; Anne-Charlotte Le Monnier de Gouville; Serge Adnot

Book ID: 110003888
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 284 KB
Volume: 125
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0702124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of the phosphodiesterase type 5 i

Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension

✍ Hori, Yasutomo; Kondo, Chigusa; Matsui, Maho; Yamagishi, Maki; Okano, Shozo; Chi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 707 KB

Differential Effects of Phosphodiesteras

Differential Effects of Phosphodiesterase-5 Inhibitors on Hypoxic Pulmonary Vasoconstriction and Pulmonary Artery Cytokine Expression

✍ Ben M. Tsai; Mark W. Turrentine; Brett C. Sheridan; Meijing Wang; Andrew C. Fior 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Effects of Roflumilast, a Phosphodiester

Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats

✍ Izikki, M.; Raffestin, B.; Klar, J.; Hatzelmann, A.; Marx, D.; Tenor, H.; Zadigu 📂 Article 📅 2009 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 411 KB

The phosphodiesterase 5 inhibitor, silde

The phosphodiesterase 5 inhibitor, sildenafil, further augments the compensatory upregulation of NO-cGMP signalling in hypoxic pulmonary hypertension

✍ Mark Kirsch; Norbert Weissmann; Barbara Kemp-Harper; Friedrich Grimminger; Haral 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 198 KB

The regulatory effect of hydrogen sulfid

The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats

✍ Zhang Chunyu; Du Junbao; Bu Dingfang; Yan Hui; Tang Xiuying; Tang Chaoshu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Right Ventricular Function and Pulmonary

Right Ventricular Function and Pulmonary Artery Compliance Improve with Phosphodiesterase type 5A (PDE5A) Inhibitor Therapy in Pulmonary Hypertension

✍ Patarroyo Aponte, M.M.; Pritzker, M.R.; Weir, K.; Sharma, A.; Rasmussen, J.; The 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 123 KB